Find a Clinical Trial
Filter
DEFENDO Long-Term Follow-Up Study
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
SEER-2
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
POETYK SjS-1
Sjogren's syndrome
All genders
18+
Recruiting now
Department of Ophthalmology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
BALATON
Macular degeneration
All genders
18+
Recruiting now
Department of Ophthalmology
Belvedere
Macular degeneration
All genders
50+
Recruiting now
Department of Ophthalmology
KPI-012-C-001
Corneal disorders
All genders
18+
Recruiting now
Department of Ophthalmology
Discovery
Glaucoma
All genders
No minimum age
Recruiting now
Department of Ophthalmology
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology
Home and Bedside Visual Fields
Vision health
All genders
15-80
Recruiting now
Department of Ophthalmology